Add to watchlist
Back to selection

 

20458-01 - Lecture with practical courses: Essentials in Drug Development & Clinical Trials (2 CP)

Semester spring semester 2026
Course frequency Every spring sem.
Lecturers Matthias Schwenkglenks (m.schwenkglenks@unibas.ch)
Aita Signorell (aita.signorell@unibas.ch, Assessor)
Content This lecture provides an overview of the operational and decision-making processes involved in modern drug development. Using real-world examples, students learn how unmet medical needs and burden of disease shape target product profiles and influence development strategies. The course covers key stages of drug development, including preclinical and clinical phases, clinical trial design, risk management and safety monitoring, chemistry, manufacturing and controls (CMC), and post-development considerations such as access, affordability, and effectiveness in real-world settings.
The lecture will combine teaching on drug development and clinical trial regulations (pathway of drug development, ethical principles, ICH-GCP, regulatory requirements) as well as practical exercises. The homework assignment will be a group activity to develop a written information and PPT presentation on various current regulatory topics.

Topics covered:
Health priorities and product development
Transition from pre-clinical to clinical development
Introduction to Pharma Market & R&D
The drug development process
Trial design
Research ethics
Regulations and authorities
Patient safety and pharmacovigilance
Risk assessment- and management
Clinical data management
Trial documentation
Quality system and SOPs
Chemistry, Manufacturing, and Controls (CMC) in drug development
Access
From efficacy to effectiveness
Trial operations and practical aspects
Insight into real clinical trials (examples)
Insight into real drug development (example)
Jobs around clinical research
Learning objectives To know the development pathway of a drug: to be familiar with the theoretical principles of good clinical practice (GCP) and research ethics with special attention to developing countries; to acquire basic knowledge on clinical trial operations including practical skills to draft the content of a clinical trial protocol and document patient information.
Bibliography Helsinki Declaration, Version 2024 Helsinki - detailed pre-reading required
Guideline ICH E8(R1) General Considerations for Clinical Trials - detailed pre-reading required
Guideline ICH E6(R3) GCP - superficial reading sufficient; please focus on glossary and principles sections
Comments Workload: 60 hours - 32 lessons, 28 hours of homework assignment (group task)

 

Admission requirements No specific prior knowledge required.
As English is the language of instruction, participants are expected to be competent in written and spoken English.
Language of instruction English
Use of digital media No specific media used
Course auditors welcome

 

Interval Weekday Time Room
Block See individual dates

Dates

Date Time Room
Thursday 26.02.2026 08.15-17.00 Swiss TPH Neubau, Seminarraum 2
Friday 27.02.2026 08.15-17.00 Swiss TPH Neubau, Seminarraum 2
Thursday 26.03.2026 08.15-17.00 Swiss TPH Neubau, Seminarraum 5
Friday 27.03.2026 08.15-17.00 Swiss TPH Neubau, Seminarraum 5
Modules Doctorate Science Epidemiology: Recommendations (PhD subject: Epidemiology (Start of studies before 01.08.2025))
Module: Advances in Epidemiology, Statistics and Global & Public Health (Master's Studies: Epidemiology)
Module: Electives in Infection Biology (Master's Studies: Infection Biology)
Assessment format continuous assessment
Assessment details Satisfactory homework assignment (rectification may be required if classified as unsatisfactory)
Multiple choice test (70% correct responses); 1 repetition
Assessment registration/deregistration Reg.: course registration, dereg: cancel course registration
Repeat examination no repeat examination
Scale Pass / Fail
Repeated registration as often as necessary
Responsible faculty Faculty of Science, studiendekanat-philnat@unibas.ch
Offered by Schweizerisches Tropen- und Public Health-Institut

Back to selection